Stock comparison
ORACLE CORP is 103.0x more valuable than Cellebrite DI Ltd. by market capitalization ($414.35 B vs $4.02 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
ORCL is larger
ORACLE CORP is 103.0x more valuable than Cellebrite DI Ltd. by market capitalization ($414.35 B vs $4.02 B).
Market value leader
ORCL
ORACLE CORP is 103.0x more valuable than Cellebrite DI Ltd. by market capitalization ($414.35 B vs $4.02 B).
Revenue leader
ORCL
CLBT: $475.68M vs ORCL: $57.40B.
Profit leader
ORCL
CLBT: $78.33M vs ORCL: $12.44B.
Margin leader
ORCL
CLBT: 16.5% vs ORCL: 21.7% net margin.
| Metric | CLBT | ORCL |
|---|---|---|
| Market cap | $4.02 B | $414.35 B |
| US-listed rank | #1594 | #29 |
| Revenue (latest FY) | $475.68M | $57.40B |
| Net income (latest FY) | $78.33M | $12.44B |
| Net margin | 16.5% | 21.7% |
| P/E (trailing FY) | 51.4x | 33.3x |
| SEC filings | 319 | 1,002 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ORACLE CORP is 103.0x more valuable than Cellebrite DI Ltd. by market capitalization ($414.35 B vs $4.02 B).
In their latest fiscal years, Cellebrite DI Ltd. reported $475.68M in revenue while ORACLE CORP reported $57.40B.
Full pages: Cellebrite DI Ltd. and ORACLE CORP, or browse the full rankings.